Evaluation of Low Level Laser Therapy and Lidocaine Versus Chlorhexidine for the Management of Traumatic Oral Ulcers in Children
NCT ID: NCT07138586
Last Updated: 2025-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2025-01-24
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Anti-anaesthetic Effects of Low-Level Laser Therapy on Children's Soft Tissue
NCT06193460
Diode Laser on the Reversal of Inferior Alveolar Nerve Block Anesthesia in Children
NCT05648981
Lidocaine Gel 2% and Muscle Traction Pain During Squint Surgery in Pediatrics
NCT04859062
Reversal of Anaesthesia with Diode Laser
NCT06841120
Effectiveness of Laser Photobiomodulation Therapy in Reducing Child Pain During Local Anesthesia Injection
NCT05861154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Assessment was done by evaluating pain by Visual Analogue scale; VAS (primary outcome) and assessment of ulcer size by periodontal probe (Secondary outcome) and Parental acceptance of the therapy (tertiary outcome) immediately after treatment, at day two, five, seven, then at two weeks
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low level laser therapy group
patients received low level laser therapy using diode laser 980 nm
low level laser therapy group
patients received low level laser therapy using diode laser 980 nm with a low power
Lidocaine gel group
patients were instructed to use Lidocaine gel (Oracure gel) 4 times daily.
Lidocaine gel group
patients was instructed to use Lidocaine gel (Oracure gel) 4 times daily.
Chlorhexidine mouthwash group (positive control group).
patients were instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).
Chlorhexidine mouthwash group (positive control group).
patients was instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low level laser therapy group
patients received low level laser therapy using diode laser 980 nm with a low power
Lidocaine gel group
patients was instructed to use Lidocaine gel (Oracure gel) 4 times daily.
Chlorhexidine mouthwash group (positive control group).
patients was instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children with history of receiving a dental procedure in the same or the previous day of the onset of ulcer.
* Children having restorations or teeth with sharp edges.
* Children with orthodontic or any other oral appliance.
* No previous treatment with any modality for the ulcer.
* Willingness to participate in the proposed clinical study.
Exclusion Criteria
* Patient under anticoagulants, anti-inflammatory or immunosuppressant medications.
* Children with systemic (endocrine-metabolic) disease; rheumatologic disease; hormone disorder; immunodeficiency; use of corticoid-based therapy.
* Uncooperative children or parents.
* Patients who did not participate twice weekly in the evaluations were excluded
4 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Centre, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maryam m El Mansy, researcher
Role: PRINCIPAL_INVESTIGATOR
The National Research Centre, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the National research Centre
Dokki, Giza Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0342
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.